{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:47:58Z","timestamp":1790808478742,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.transci.2020.102744","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T01:15:08Z","timestamp":1584494108000},"page":"102744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The role of therapeutic plasmapheresis in patients with hyperthyroidism"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-3182","authenticated-orcid":false,"given":"Ozden","family":"Ozdemir Baser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Catak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Koseoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Berker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.transci.2020.102744_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism","volume":"2018","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"26","key":"10.1016\/j.transci.2020.102744_bib0010","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"2016","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.transci.2020.102744_bib0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2004.02135.x","article-title":"Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK","volume":"61","author":"Pearce","year":"2004","journal-title":"Clin Endocrinol."},{"key":"10.1016\/j.transci.2020.102744_bib0020","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1089\/thy.2011.0353","article-title":"Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis","volume":"22","author":"Jha","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.transci.2020.102744_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102744_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12020-018-1661-x","article-title":"Therapeutic plasmapheresis in thyrotoxic patients","volume":"62","author":"Simsir","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.transci.2020.102744_bib0035","article-title":"Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review of the literature","volume":"2018","author":"Garla","year":"2018","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.transci.2020.102744_bib0040","first-page":"EJ16","article-title":"Guidelines for the management of thyroid storm from the Japan Thyroid Association and Japan Endocrine Society","volume":"2016","author":"Satoh","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.transci.2020.102744_bib0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures","volume":"22","author":"Shemin","year":"2007","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102744_bib0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2005.00319.x","article-title":"Complications of therapeutic plasma exchange: experience with 4857 treatments","volume":"9","author":"Basic\u2010Jukic","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2020.102744_bib0055","series-title":"A compendium of transfusion practice guidelines","author":"Gary Bachowski","year":"2017"},{"key":"10.1016\/j.transci.2020.102744_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jca.20200","article-title":"Preoperative therapeutic plasma exchange in patients with thyrotoxicosis","volume":"24","author":"Ezer","year":"2009","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.transci.2020.102744_bib0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.transci.2013.04.010","article-title":"The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study","volume":"48","author":"Keklik","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2020.102744_bib0070","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1345\/aph.1G720","article-title":"Aguilar-Diosdado M. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole","volume":"40","author":"Vilchez","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.transci.2020.102744_bib0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4158\/EP.8.3.222","article-title":"Methimazole-induced hepatotoxicity","volume":"8","author":"Woeber","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1016\/j.transci.2020.102744_bib0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug\u2010related hepatotoxicity in hyperthyroidism patients: a population\u2010based cohort study","volume":"78","author":"Wang","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transci.2020.102744_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/thy.2014.0350","article-title":"Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China","volume":"25","author":"Yang","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.transci.2020.102744_bib0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jca.20014","article-title":"Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: a case report","volume":"19","author":"Guvenc","year":"2004","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.transci.2020.102744_bib0095","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: mayo Clinic experience","volume":"28","author":"Houghton","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.transci.2020.102744_bib0100","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.transci.2020.102744_bib0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"2018","author":"Bartalena","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.transci.2020.102744_bib0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002018-200629030-00006","article-title":"Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis","volume":"29","author":"Uzan","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.transci.2020.102744_bib0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1444-0903.2004.00600.x","article-title":"Plasmapheresis as a potential treatment option for amiodarone\u2010induced thyrotoxicosis","volume":"34","author":"Diamond","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.transci.2020.102744_bib0120","first-page":"45","article-title":"Total thyroidectomy for amiodarone-induced thyrotoxicosis in the hyperthyroid state","volume":"124","author":"Kaderli","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.transci.2020.102744_bib0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.transci.2006.05.017","article-title":"Hyperthyroidism in molar pregnancy: rapid preoperative preparation by plasmapheresis and complete improvement after evacuation","volume":"36","author":"Azezli","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2020.102744_bib0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00404-008-0762-9","article-title":"The use of plasmapheresis for rapid hormonal control in severe hyperthyroidism caused by a partial molar pregnancy","volume":"279","author":"Adali","year":"2009","journal-title":"Arch Gynecol Obstet"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220300318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220300318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:55Z","timestamp":1761468715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220300318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1473050220300318"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102744","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of therapeutic plasmapheresis in patients with hyperthyroidism","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102744"}}